Actively Recruiting
Screening Biomarkers for Early Diagnosis of Osteoarthritis in Adults Aged 40 to 70 Years
Led by The First Affiliated Hospital of Xinxiang Medical College · Updated on 2026-04-22
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Osteoarthritis OA is the most common degenerative joint disease worldwide, especially affecting people over 60 years old. In China, OA cases are rising rapidly due to aging and lifestyle changes, with projections exceeding 200 million patients by 2044. This research aims to find reliable biomarkers for early diagnosis to improve prevention, diagnosis, and personalized treatment of OA, focusing on patients with early-stage disease and those with similar symptoms prone to misdiagnosis. The study will collect blood samples from patients with OA, mainly targeting joints like the knee, hip, and hand. Participants include early-stage OA patients with specific imaging grades and those suspected of having OA. Diagnostic tests will verify previously reported candidate biomarkers, helping to identify those with strong clinical value. This observational study does not involve treatment but focuses on gathering clinical, imaging, and biological data to develop early diagnostic methods. Participants will undergo diagnostic evaluations at enrollment and provide blood samples for biomarker screening about 100 days later. Researchers will assess joint pain, stiffness, imaging results, and other clinical features. Follow-up visits and examinations like X-rays and MRIs are part of the study. The goal is to analyze data to support early detection and individualized care for OA, with a study duration extending until the end of 2026.
CONDITIONS
Brief Title
Screening for Biomarkers of Osteoarthritis
Research Team
W
Wenjie Ren
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here